Jackson, Grant Investment Advisers, Inc. Gilead Sciences, Inc. Transaction History

Jackson, Grant Investment Advisers, Inc.

$256 Million
Q1 2025

A detailed history of Jackson, Grant Investment Advisers, Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Jackson, Grant Investment Advisers, Inc. holds 1,104 shares of GILD stock, worth $113,160. This represents 0.05% of its overall portfolio holdings.

Number of Shares

1,104

Previous 1,103 0.09%

Holding current value

$113,160

Previous $101,000 21.78%

% of portfolio

0.05%

Previous 0.04%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 06, 2025	BUY	$89.14 - $117.41 $89 - $117	1 Added 0.09%	1,104 $123,000
Q4 2024 Jan 27, 2025	BUY	$83.95 - $97.9 $83 - $97	1 Added 0.09%	1,103 $101,000
Q3 2024 Oct 17, 2024	BUY	$66.59 - $83.99 $133 - $167	2 Added 0.18%	1,102 $92,000
Q2 2024 Jul 16, 2024	BUY	$63.15 - $72.88 $8,588 - $9,911	136 Added 14.11%	1,100 $75,000
Q3 2023 Oct 13, 2023	SELL	$73.94 - $80.67 $4,953 - $5,404	-67 Reduced 6.5%	964 $72,000
Q1 2023 May 02, 2023	BUY	$77.31 - $88.08 $5,179 - $5,901	67 Added 6.95%	1,031 $85,000
Q1 2022 Apr 28, 2022	SELL	$57.92 - $72.58 $5,270 - $6,604	-91 Reduced 8.63%	964 $57,000
Q3 2021 Oct 13, 2021	BUY	$67.69 - $73.03 $19,427 - $20,959	287 Added 37.37%	1,055 $74,000
Q2 2021 Jul 15, 2021	BUY	$63.47 - $69.35 $1,205 - $1,317	19 Added 2.54%	768 $53,000
Q1 2021 Apr 22, 2021	BUY	$60.0 - $68.46 $300 - $342	5 Added 0.67%	749 $48,000
Q4 2020 Mar 03, 2021	BUY	$56.65 - $64.55 $339 - $387	6 Added 0.81%	744 $43,000
Q3 2020 Nov 12, 2020	BUY	$62.1 - $78.08 $310 - $390	5 Added 0.68%	738 $47,000
Q2 2020 Aug 14, 2020	BUY	$72.34 - $84.0 $361 - $420	5 Added 0.69%	733 $56,000
Q1 2020 May 12, 2020	BUY	$62.63 - $80.22 $9,269 - $11,872	148 Added 25.52%	728 $54,000
Q4 2019 Feb 05, 2020	SELL	$61.62 - $67.78 $15,466 - $17,012	-251 Reduced 30.2%	580 $38,000
Q3 2019 Nov 20, 2019	BUY	$62.51 - $69.0 $250 - $276	4 Added 0.48%	831 $53,000
Q2 2019 Aug 13, 2019	BUY	$61.87 - $69.38 $309 - $346	5 Added 0.61%	827 $56,000
Q1 2019 May 07, 2019	BUY	$62.53 - $70.05 $6,565 - $7,355	105 Added 14.64%	822 $53,000
Q4 2018 Jan 23, 2019	BUY	$60.54 - $79.0 $15,740 - $20,540	260 Added 56.89%	717 $45,000
Q3 2018 Nov 15, 2018	BUY	$71.28 - $78.92 $285 - $315	4 Added 0.88%	457 $35,000
Q2 2018 Aug 02, 2018	BUY	$64.88 - $75.68 $194 - $227	3 Added 0.67%	453 $32,000
Q1 2018 May 14, 2018	BUY	$72.84 - $88.8 $291 - $355	4 Added 0.9%	450 $34,000
Q4 2017 Feb 01, 2018	BUY	$71.15 - $83.52 $213 - $250	3 Added 0.68%	446 $32,000
Q3 2017 Nov 14, 2017	BUY	$72.11 - $85.47 $216 - $256	3 Added 0.68%	443 $36,000
Q2 2017 Aug 10, 2017	BUY	N/A	440	440 $31,000

Others Institutions Holding GILD

# of Institutions

2,284

Shares Held

996M

Call Options Held

9.62M

Put Options Held

10M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $128B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jackson, Grant Investment Advisers, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Jackson, Grant Investment Advisers, Inc. with notifications on news.

Account

Jackson, Grant Investment Advisers, Inc. Gilead Sciences, Inc. Transaction History